Your browser doesn't support javascript.
loading
PET/Computed Tomography Transformation of Oncology: Immunotherapy Assessment.
Ghodsi, Alireza; Hicks, Rodney J; Iravani, Amir.
Afiliación
  • Ghodsi A; Department of Radiology, University of Washington, 1144 Eastlake Avenue East, Seattle, WA 98109, USA.
  • Hicks RJ; Department of Medicine, St Vincent's Hospital, The University of Melbourne, Australia; Department of Medicine, Central Clinical School, The Alfred Hospital, Monash University, Melbourne, Australia; The Melbourne Theranostic Innovation Centre, North Melbourne, Australia.
  • Iravani A; Department of Radiology, University of Washington, 1144 Eastlake Avenue East, Seattle, WA 98109, USA. Electronic address: airavani@uw.edu.
PET Clin ; 19(2): 291-306, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38199917
ABSTRACT
Immunotherapy approaches have changed the treatment landscape in a variety of malignancies with a high anti-tumor response. Immunotherapy may be associated with novel response and progression patterns that pose a substantial challenge to the conventional criteria for assessing treatment response, including response evaluation criteria in solid tumors (RECIST) 1.1. In addition to the morphologic details provided by computed tomography (CT) and MRI, hybrid molecular imaging emerges as a comprehensive imaging modality with the capacity to interrogate pathophysiological mechanisms like glucose metabolism. This review highlights the current status of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography (18F-FDG PET/CT) in prognostication, response monitoring, and identifying immune-related adverse events. Furthermore, it investigates the potential role of novel immuno-PET tracers that could complement the utilization of 18F-FDG PET/CT by imaging the specific pathways involved in immunotherapeutic strategies.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fluorodesoxiglucosa F18 / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: PET Clin Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fluorodesoxiglucosa F18 / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: PET Clin Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos